HCA
MRNA icon

Harbor Capital Advisors’s Moderna MRNA Stock Holding History

Harbor Capital Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,123
Closed -$677K – 1345
2024
Q3 		$677K Sell
10,123
-284
-3% -$26.1K 0.03% 524
2024
Q2 		$1.24M Buy
10,407
+1,095
+12% +$139K 0.09% 297
2024
Q1 		$992K Sell
9,312
-530
-5% -$53.4K 0.13% 216
2023
Q4 		$979K Buy
9,842
+4,118
+72% +$346K 0.19% 133
2023
Q3 		$591K Sell
5,724
-336
-6% -$37.5K 0.13% 200
2023
Q2 		$736K Buy
+6,060
New +$808K 0.15% 182

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Harbor Capital Advisors's MRNA Position: Q4 2024 in Review

Harbor Capital Advisors sold out of Moderna (MRNA) in Q4 2024, closing a stake of 10,123 shares — an estimated $677K sold.

Harbor Capital Advisors first reported a position in MRNA in Q2 2023 and held it in 6 quarters. The position peaked at $1.24M in Q2 2024. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Harbor Capital Advisors reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Harbor Capital Advisors sold 10,123 Moderna shares in Q4 2024, an estimated $677K.
  • Harbor Capital Advisors first reported a position in Moderna in Q2 2023 and held it in 6 quarters.
  • Harbor Capital Advisors's Moderna position peaked at $1.24M in Q2 2024.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Harbor Capital Advisors's 13F filing for Q4 2024, filed 10 Jan 2025.